Repurposing of Rutan showed effective treatment for COVID-19 disease

Previously, from the tannic sumac plant (Rhus coriaria), we developed the Rutan 25 mg oral drug tablets with antiviral activity against influenza A and B viruses, adenoviruses, paramyxoviruses, herpes virus, and cytomegalovirus. Here, our re-purposing study demonstrated that Rutan at 25, 50, and 100 mg/kg provided a very effective and safe treatment for COVID-19 infection, simultaneously inhibiting two vital enzyme systems of the SARS-CoV-2 virus: 3C-like proteinase (3CLpro) and RNA-dependent RNA polymerase (RdRp). There was no drug accumulation in experimental animals’ organs and tissues. A clinical study demonstrated a statistically significant decrease in the C-reactive protein and a reduction of the viremia period. In patients receiving Rutan 25 mg (children) and 100 mg (adults), the frequency of post-COVID-19 manifestations was significantly less than in the control groups not treated with Rutan tablets. Rutan, having antiviral activity, can provide safe treatment and prevention of COVID-19 in adults and children.Clinical Trial RegistrationClinicalTrials.gov, ID NCT05862883

Solubility of YbTe in Sb2Te3 and thermodynamic properties of the solid solution

International audienceThe solubility of YbTe in Sb2Te3 is investigated by a combination of DTA, XRD, SEM, and EMF methods. The fragment of the T-x phase diagram of the YbTe-Sb2Te3 system is constructed for 0-25 mol.% YbTe. It is shown that the solubility limit for YbTe in Sb2Te3 is achieved at 15 mol.% YbTe at 300 K and at 17.5 mol.% YbTe at 855 K. From the EMF measurements with an YbTe electrode the partial thermodynamic functions of the YbTe pseudo-component are calculated for the alloys of different compositions. Also, the standard integral thermodynamic functions of the YbTe dissolution in Sb2Te3 as well as the standard thermodynamic functions of formation and the standard entropy of the solid solution are calculated from the experimental data

Serum Zinc Concentration and Acute Diarrhea in Children from Different Regions of Uzbekistan

OBJECTIVE: To study the blood serum zinc concentration in children with acute diarrhea (AD) in in-patient facilities before and after therapy. INTRODUCTION: There are several reports of zinc deficiency in pathogenesis of acute and chronic diarrhea. The literature review showed children with diarrhea and chronic gastroduodenitis performed zinc deficiency in majority of cases (1). The normal values of zinc in blood serum are 12.8–27.8 μmol/l (2). There is a threshold of 13μmol/l zinc concentration for zinc deficiency diagnosis. The zinc level 8.2 μmol/l and below is poor prognostic criteria (3). METHODS: Totally 102 children (1–14 years old) with AD in in-patient facility from different regions were studied for serum zinc concentration before and after treatment. Termez and Saraosie cities are located in south of Uzbekistan, in the region with high negative impact from the nearly Tajikistan located aluminum producing plant. The serum zinc level measured by neutron-activation method in the Institute of Nuclear Research (INR). RESULTS: The zinc concentration in serum significantly varied by the region (Table 1). The level of zinc in children from Tashkent estimated at lower normal limit with reduction below normal values after treatment. Children from Termez during admission to the in-patient facilities were zinc deficient with further reduction to the poor prognostic level. Children in Saraosie admitted to the in-patient with significant zinc deficiency that remained on poor prognostic level after treatment. CONCLUSIONS: The study results may indicate the treatment of AD in children do not replenish the zinc to the appropriate level. Though some confounding factors may contribute the observed zinc disorders the results may indicate environmental factors, such as pollution by aluminum producing plant emission to contribute the difference in zinc concentration and should be considered for the correction and treatment of AD in children